WASHINGTON--(BUSINESS WIRE)--The following statement was issued by Biotechnology Industry Organization President and CEO Jim Greenwood regarding legislation introduced today by Reps. Henry Waxman (D-CA), Frank Pallone (D-NJ), and Nathan Deal (R-GA) to establish a pathway for the approval of biosimilars:
